logo
Login

MEDICAMEN BIOTECH LIMITED (MEDICAMEQ) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 1993, Medicamen Biotech Ltd is a research-led pharmaceutical company involved in developing, manufacturing, and marketing generic finished dosage formulations, and Oncology Formulations[1]

MEDICAMEQUpdated 1 Sept 2026, 7:15

Medicamen Biotech Limited

Market Cap

₹355Cr.

Current Price

₹261

High / Low

₹454/210

Stock P/E

34.4

ROE3.78%
ROCE5.10%
Book Value₹206
Face Value₹10.0
Dividend Yield0.38%

About

Incorporated in 1993, Medicamen Biotech Ltd is a research-led pharmaceutical company involved in developing, manufacturing, and marketing generic finished dosage formulations, and Oncology Formulations[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days12487114126129137165193159102141132
Inventory Days959510277678528188230237274258
Days Payable187160165118134160161291232152182138
Cash Conversion Cycle3222518562623291157188234252
Working Capital Days733489116139130146151117186197
ROCE %12%12%24%25%20%15%13%12%11%10%7%5%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 7:15

Designed & Shipped by Harshit Bansal